欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SK/H/0262/001
药品名称
Rupatadin Vivax 10 mg tablety
活性成分
rupatadine fumarate 10.0 mg
剂型
Tablet
上市许可持有人
Noucor Health S.A.
参考成员国 - 产品名称
Slovakia (SK)
互认成员国 - 产品名称
Portugal (PT)
Italy (IT)
Poland (PL)
Rupatadine Uriach
许可日期
2015/09/14
最近更新日期
2024/03/15
药物ATC编码
R06A ANTIHISTAMINES FOR SYSTEMIC USE
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final PL
|
Rupatadine Vivax SK_H_0262_001_IB_006_G common_PL
Date of last change:2022/09/14
Final Product Information
|
Rupatadine Vivax SK-H-0262-001-IB-004 common-PL-tracked
Date of last change:2021/02/03
Final Product Information
|
Rupatadine Vivax SK-H-0262-001-IB-004 common-PL-clean
Date of last change:2021/02/03
Final Product Information
|
Rupatadine Vivax SK-H-0262-001-IB-004 common-SmPC-clean
Date of last change:2021/02/03
Final Product Information
|
Rupatadine Vivax SK-H-0262-001-IB-004 common-SmPC_tracked
Date of last change:2021/02/03
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase